The trial enrolled 44 participants with symptomatic oHCM. Credit: NMK-Studio / Shutterstock.com. Bristol Myers Squibb (BMS) has announced positive top line results from the Phase III SCOUT-HCM trial ...
The MHRA will implement a 14-day assessment process for phase I trials to expedite early new medicine testing. Credit: Wasan Tita / Shutterstock.com. The UK has announced new clinical trial regulatory ...
BioAge’s NLRP3 inhibitor has shown potential to reduce high-sensitivity C-reactive protein (hsCRP), a key marker of ...
Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.
MRM Health has received clearance from the FDA for its IND application, enabling the company to start the STARFISH-UC Phase ...
The Beeline trial uses a disease-specific endpoint, the GRIN-specific Clinical Global Impression (GRIN-CGI) scale, developed with caregivers’ input. Credit: PanuShot / Shutterstock.com. GRIN ...
Lynk Pharmaceuticals’ next generation JAK inhibitor, zemprocitinib, has met its primary and secondary trial endpoints during a Phase III study in rheumatoid arthritis. Image credit: one photo via ...
These results tout the potential Eli Lilly's Taltz-Zepbound as the new SoC for PsA patients with comorbid obesity.
In the Phase Ib JADE trial, OLN324 demonstrated both faster and greater retinal drying versus Vabysmo in patients with DME, ...
The Mount Sinai TCC has introduced an AI clinical trial matching platform, PRISM, to improve access to cancer research ...
NRG Therapeutics has dosed the first participants in its Phase I clinical trial of NRG5051, being developed as a ...
Medical Devices includes a session from a regulatory expert on how companies can align their research between regions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback